JAMIE FREDERICK: Open Payments
NPI 1629550165 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 33 payments from 11 companies in 2025. Trend: 2023 $94 · 2024 $240 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 18 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Biogen, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Indivior Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: INVEGA SUSTENNA, CAPLYTA, FANAPT, ZURZUVAE, AUSTEDO XR, TRINTELLIX, SUBLOCADE, ABILIFY MAINTENA.
Industry payments across IN — which companies pay providers there.
